Results 201 to 210 of about 370,229 (352)
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no FDA‐approved disease‐modifying therapies for SjD.
Rachael A. Gordon, Sara S. McCoy
wiley +1 more source
Cutaneous lupus erythematosus - from pathogenesis to targeted therapy. [PDF]
Klein B +3 more
europepmc +1 more source
Corticosteroids and Cholelithiasis in Systemic Lupus Erythematosus [PDF]
Т. М. Reshetnyak +3 more
openalex +1 more source
Hypertension and its complications in a young man with autoimmune disease [PDF]
Basile, Jan N. +9 more
core +1 more source
Objective The therapeutic effects of telitacicept combined with standard of care (SoC) in childhood‐onset systemic lupus erythematosus (cSLE) remain unclear. This study aims to evaluate its efficacy in comparison with belimumab combined with SoC.
Chong Luo +15 more
wiley +1 more source
Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls [PDF]
Irene E. M. Bultink +3 more
openalex +1 more source
Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?
Objective Lupus nephritis (LN) is characterized by a variable disease course, necessitating continuous monitoring. There is an urgent need to identify non‐invasive biomarkers. By reviewing and critically assessing the quality of existing studies on LN biomarkers correlating with histopathology, we here explore the challenges in promoting their use in ...
Valentina Querin +11 more
wiley +1 more source
A Rare Case of Coexistence: Discoid Lupus Erythematosus and Sturge-Weber Syndrome. [PDF]
Efazati A +4 more
europepmc +1 more source
Objective Systemic lupus erythematosus (SLE) is characterized by increased type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama +16 more
wiley +1 more source

